December ACCV Prebunk

On December 29, 2025, the Advisory Commission on Childhood Vaccines (ACCV) is scheduled to hold four meetings in a single afternoon, despite being chartered to meet quarterly and not having convened since July 2024, with a January 2025 meeting postponed indefinitely. The meeting’s timing, during a period of predictably low attendance and media attention, raises concerns about transparency and oversight. Although no votes are scheduled, the discussions could significantly influence the future of vaccine injury compensation, public trust, and vaccine access. This briefing provides background on the Vaccine Injury Compensation Program (VICP) and the ACCV, outlines communication guidance, and examines risks posed by changes not grounded in scientific consensus. While public focus remains on turmoil within ACIP, the ACCV represents a quieter but potentially consequential pathway for structural shifts affecting manufacturers, access, and confidence in the vaccination system.